AlphaLeaf Blog

Insights, updates, and expert knowledge on cannabis cultivation, compliance, and industry trends.

How to Structure a B2B Cannabis Supply Agreement with a Canadian LP: 2026 Guide

How to Structure a B2B Cannabis Supply Agreement with a Canadian LP: 2026 Guide

A practical guide for international cannabis importers on structuring a B2B supply agreement with a Canadian Licensed Producer: core clauses, Health Canada export compliance, market-specific regulatory addenda for Germany, Australia, and Israel, and offtake structures.

Julie Lefebvre
Julie LefebvreJune 11, 2026
Cannabis Supply Agreement Terms: What B2B Buyers Should Negotiate Before Signing (2026)

Cannabis Supply Agreement Terms: What B2B Buyers Should Negotiate Before Signing (2026)

Five contract clauses every B2B cannabis buyer should negotiate before signing a supply agreement with a Canadian Licensed Producer.

Julie Lefebvre
Julie LefebvreJune 10, 2026
Israel IMCA Cannabis Import Permit Requirements: A Guide for Canadian LPs in 2026

Israel IMCA Cannabis Import Permit Requirements: A Guide for Canadian LPs in 2026

A step-by-step guide to Israel's IMCA cannabis import permit process for Canadian LPs, covering IMC-GMP alignment, the 7-document qualification package, and first-shipment timelines.

Julie Lefebvre
Julie LefebvreJune 9, 2026
How to Export Cannabis from Canada to Australia in 2026: TGA, ODC, and TGO 93 Requirements

How to Export Cannabis from Canada to Australia in 2026: TGA, ODC, and TGO 93 Requirements

A complete guide for Canadian Licensed Producers on exporting cannabis to Australia in 2026, covering TGA access pathways, ODC import permits, TGO 93 quality specifications, and Health Canada export permit requirements.

Natalie Rousseau
Natalie RousseauJune 8, 2026
Exporting Cannabis from Canada to Brazil in 2026: A Canadian LP Guide

Exporting Cannabis from Canada to Brazil in 2026: A Canadian LP Guide

Brazil's medical cannabis import channel is growing, and Canadian Licensed Producers are well positioned to supply it. This guide covers ANVISA's import framework, the Health Canada export permit process, GMP documentation requirements, and realistic supply chain timelines for 2026.

Madeleine Côté
Madeleine CôtéJune 5, 2026
Cannabis B2B Supply Agreement Terms in 2026: What to Negotiate

Cannabis B2B Supply Agreement Terms in 2026: What to Negotiate

A cannabis B2B supply agreement decides who absorbs a rejected batch, who carries currency risk, and what happens when a permit lapses. This guide covers the quality, pricing, regulatory, and termination terms procurement and business development teams should negotiate with a Canadian LP.

Julie Lefebvre
Julie LefebvreJune 5, 2026
Cannabis Stability and Shelf-Life Testing: A B2B Buyer's Guide 2026

Cannabis Stability and Shelf-Life Testing: A B2B Buyer's Guide 2026

A single COA is a snapshot; stability testing shows how a batch holds up through transit and storage. What B2B buyers should ask a Canadian LP to provide.

Isabelle Fontaine
Isabelle FontaineJune 5, 2026
Exporting Cannabis to Australia in 2026: A Canadian LP Guide

Exporting Cannabis to Australia in 2026: A Canadian LP Guide

A practical compliance guide for Canadian LPs entering the Australian medical cannabis market in 2026, covering TGA and ODC requirements, TGO 93 product standards, and the five-step export path.

Natalie Rousseau
Natalie RousseauJune 5, 2026
Cannabis Contaminant Testing Limits in 2026: A B2B Buyer's Guide

Cannabis Contaminant Testing Limits in 2026: A B2B Buyer's Guide

Cannabis contaminant testing limits are not a single fixed table. This B2B guide explains the four COA contaminant panels, how Health Canada ties limits to pharmacopoeial standards and route of use, where EU buyers raise the bar, and a four-point checklist for verifying an incoming batch.

Isabelle Fontaine
Isabelle FontaineJune 5, 2026
EU Cannabis Import by Country in 2026: A Canadian LP Comparison Guide

EU Cannabis Import by Country in 2026: A Canadian LP Comparison Guide

There is no single EU cannabis import framework. This guide compares the four most relevant EU medical cannabis markets for a Canadian LP in 2026, with the regulator, quality standard, and entry friction for each, plus a sequenced market-entry path.

Sophie Tremblay
Sophie TremblayJune 5, 2026
GPP Audit Preparation for Canadian Cannabis LPs in 2026

GPP Audit Preparation for Canadian Cannabis LPs in 2026

A GPP audit checks whether your quality systems work in practice. How Canadian LPs stay audit-ready year-round and why it protects export continuity.

Élise Gauthier
Élise GauthierJune 5, 2026
Exporting Cannabis to Israel from Canada in 2026: What Licensed Producers Need to Know

Exporting Cannabis to Israel from Canada in 2026: What Licensed Producers Need to Know

A practical guide for Canadian Licensed Producers on IMCA supplier approval, IMC-GAP and IMC-GMP compliance, the Israel import permit process, and what Israeli pharmaceutical distributors evaluate in a Canadian cannabis supply partner.

Julie Lefebvre
Julie LefebvreJune 4, 2026
Premium Cannabis Cultivated in Montreal, Canada.
Health Canada Licensed.
Hand-Trimmed, Lab-Tested, and Export-Ready for Qualified Buyers Worldwide.
alphaleaf logo
All AlphaLeaf products are cannabis intended exclusively for authorized licensed buyers. Products are available only to holders of valid Canadian cannabis licences or international buyers with appropriate importation licences issued by their national regulatory authority. This website does not constitute an offer to sell in jurisdictions where such sale is prohibited. For adult use only. Keep out of reach of children. All product information is subject to change. THC percentages are approximate and may vary by batch
© 2026 AlphaLeaf Corporation. All rights reserved.